Articles by Christina I. Ortiz - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Christina I. Ortiz

Christina I. Ortiz


Christina Ortiz is an intern with Pharmaceutical Technology.

Articles
Global Healthcare on the Ground: BIO and BIO Ventures for Global Health
June 2, 2011

A Focus on Creative Strategies to Help the Developing World.

Global Healthcare on the Ground: Roche Takes on Illnesses in LDCs
May 2, 2011

Efforts are made to educate health workers in less developed countries.

FDA Releases Strategic Priorities for 2011-2015
April 28, 2011

FDA has released a list of its strategic priorities for the next five years to address new global challenges.

USP Drug Quality Pilot Program Underway in Sub-Saharan Africa
April 21, 2011

On Apr. 18, 2011, scientists from the national laboratories of five African nations gathered in Accra, Ghana, to take part in a week of technical training put on by the US Pharmacopeia (USP) that will teach them how to detect substandard and counterfeit medicines.

Global Healthcare on the Ground: Framework Set for Supply-Chain Improvement
April 2, 2011

PRTM helps to improve supply-chain management and logistics in developing countries.

Global Healthcare on the Ground: FDA Tackles Rare Diseases
March 2, 2011

FDA's efforts to improve access to treatments for rare diseases.

EMA Releases New Guidance on Stem Cell Products
February 10, 2011

On Feb. 4, 2011, the European Medicines Agency released new document on drug products that are manufactured using stem cells.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
10%
Protecting the supply chain
40%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here